| Absorption | 
      | Blood-Brain Barrier | BBB+ | 0.9781 | 
      | Human Intestinal Absorption | HIA+ | 0.9821 | 
      | Caco-2 Permeability | Caco2+ | 0.7729 | 
      | P-glycoprotein Substrate | Substrate | 0.8537 | 
      | P-glycoprotein Inhibitor | Inhibitor | 0.8170 | 
                                                     | Inhibitor | 0.8577 | 
      | Renal Organic Cation Transporter | Inhibitor | 0.7615 | 
        
            | Distribution | 
        
      | Subcellular localization | Lysosome | 0.6982 | 
        
          | Metabolism | 
        
      | CYP450 2C9 Substrate | Non-substrate | 0.7702 | 
      | CYP450 2D6 Substrate | Non-substrate | 0.5179 | 
      | CYP450 3A4 Substrate | Non-substrate | 0.5346 | 
      | CYP450 1A2 Inhibitor | Inhibitor | 0.9376 | 
      | CYP450 2C9 Inhibitor | Non-inhibitor | 0.9070 | 
        | CYP450 2D6 Inhibitor | Inhibitor | 0.9723 | 
      | CYP450 2C19 Inhibitor | Inhibitor | 0.8994 | 
      | CYP450 3A4 Inhibitor | Non-inhibitor | 0.7676 | 
      | CYP Inhibitory Promiscuity | High CYP Inhibitory Promiscuity | 0.8557 | 
        
          | Excretion | 
        
        
          | Toxicity | 
        
      | Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.8165 | 
                                                                    | Inhibitor | 0.7860 | 
      | AMES Toxicity | Non AMES toxic | 0.8999 | 
      | Carcinogens | Non-carcinogens | 0.9456 | 
      | Fish Toxicity | High FHMT | 0.9874 | 
      | Tetrahymena Pyriformis Toxicity | High TPT | 0.9869 | 
      | Honey Bee Toxicity | Low HBT | 0.8342 | 
      | Biodegradation | Not ready biodegradable | 1.0000 | 
      | Acute Oral Toxicity | III | 0.8102 | 
      | Carcinogenicity (Three-class) | Non-required | 0.7225 |